B. Melotti

A. Ardizzoni, F. Sperandi, B. Melotti, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Early palliative care and quality of life of advanced cancer patients-a multicenter randomized clinical trial.

L. Cavanna, C. Caminiti, B. Melotti, 2019, Annals of palliative medicine.

Impact of intervention aimed at improving the integration of oncology units and local palliative care services: results of the multicentre prospective sequential MIRTO study

F. Pannuti, B. Melotti, A. Martoni, 2017, ESMO Open.

C. Tibaldi, G. Fasola, G. Ceresoli, 2019, Lung cancer.

Genomic Landscape, Clinical Features and Outcomes of Non-Small Cell Lung Cancer Patients Harboring BRAF Alterations of Distinct Functional Classes

A. Ardizzoni, D. de Biase, A. Palladini, 2022, Cancers.

An unusual skin reaction in uveal melanoma during treatment with nivolumab: extragenital lichen sclerosus.

A. Patrizi, B. Melotti, E. Dika, 2019, Anti-cancer drugs.

Impact of Baseline Versus Intercurrent Steroids Administration on Upfront Chemo-Immunotherapy for Advanced Non-Small Cell Lung Cancer (NSCLC)

A. Ardizzoni, F. Sperandi, B. Melotti, 2022, International journal of molecular sciences.

Cutaneous adverse effects during ipilimumab treatment for metastatic melanoma: a prospective study

B. Piraccini, A. Patrizi, S. Ribero, 2017, European Journal of Dermatology.

Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer.

F. Sperandi, B. Melotti, F. Artioli, 2005, European journal of cancer.

Next‐generation sequencing revealing TP53 mutation as potential genetic driver in dermal deep‐seated melanoma arising in giant congenital nevus in adult patients: A unique case report and review of the literature

M. Fiorentino, A. Altimari, B. Corti, 2020, Journal of cutaneous pathology.

Randomized Trial of Low-Dose Morphine Versus Weak Opioids in Moderate Cancer Pain.

E. Bruera, L. Cavanna, F. Roila, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Patterns of renal toxicity from the combination of pemetrexed and pembrolizumab for advanced nonsquamous non-small-cell lung cancer (NSCLC): A single-center experience.

A. Ardizzoni, G. La Manna, F. Sperandi, 2022, Lung cancer.

BRAF, KIT, and NRAS Mutations of Acral Melanoma in White Patients.

M. Ferracin, B. Piraccini, M. Fiorentino, 2020, American journal of clinical pathology.

Hair and nail adverse events during treatment with targeted therapies for metastatic melanoma

B. Piraccini, M. Starace, A. Patrizi, 2016, European Journal of Dermatology.

Gemcitabine plus mitoxantrone and prednisone in the palliative treatment of hormone-resistant prostate cancer (HRPC): A phase II study (GOAM 01.01 study).

E. Amaducci, G. Martorana, B. Melotti, 2006, Anticancer research.

Oral vinorelbine plus cisplatin as first-line chemotherapy in nonsquamous non-small-cell lung cancer: final results of an International randomized phase II study (NAVotrial 01).

R. Ramlau, M. Krzakowski, J. Jassem, 2014, Clinical lung cancer.

The evolving landscape of immunotherapy in small-cell lung cancer: A focus on predictive biomarkers.

A. Ardizzoni, F. Sperandi, B. Melotti, 2019, Cancer treatment reviews.

Pembrolizumab in the treatment of metastatic non-small cell lung cancer: a review of current evidence

M. Fiorentino, A. Ardizzoni, F. Sperandi, 2017, Therapeutic advances in respiratory disease.

Clinical characteristics and treatment outcomes of non-V600 E/K BRAF mutant melanoma patients: a single-institution experience

A. Altimari, D. de Biase, F. Comito, 2022, Melanoma research.

Epirubicin metabolism and pharmacokinetics after conventional- and high-dose intravenous administration: a cross-over study

F. Pannuti, B. Melotti, A. Martoni, 2004, Cancer Chemotherapy and Pharmacology.

Early Integration of Palliative Care in Oncology Practice: Results of the Italian Association of Medical Oncology (AIOM) Survey

M. Maltoni, L. Cavanna, V. Zagonel, 2016, Journal of Cancer.

In transit melanoma and imiquimod: A case of disease progression

A. Patrizi, B. Melotti, E. Dika, 2020, Dermatologic therapy.

CEA and CYFRA 21-1 as prognostic biomarker and as a tool for treatment monitoring in advanced NSCLC treated with immune checkpoint inhibitors

A. Ardizzoni, M. Tiseo, S. Buti, 2020, Therapeutic advances in medical oncology.

Virologic and genetic evaluation of vemurafenib-induced skin cancers

B. Piraccini, M. Fiorentino, A. Altimari, 2015, Cutaneous and ocular toxicology.

Emerging Novel Therapeutic Approaches for Treatment of Advanced Cutaneous Melanoma

A. Ardizzoni, F. Comito, F. Sperandi, 2022, Cancers.

The role of topical imiquimod in melanoma cutaneous metastases: A critical review of the literature

A. Patrizi, B. Melotti, E. Dika, 2020, Dermatologic therapy.

Immunotherapy-refractory, EGFR overexpressing metastatic porocarcinoma responding to cetuximab.

A. Ardizzoni, F. Comito, F. Sperandi, 2021, European journal of cancer.

Oral Manifestations in Melanoma Patients Treated with Target or Immunomodulatory Therapies

A. Alessandrini, S. Ribero, B. Melotti, 2021, Journal of clinical medicine.

1320PUse of nivolumab in elderly patients with advanced non-squamous NSCLC: Results from the Italian expanded access program (EAP)

E. Vasile, S. Cascinu, F. Verderame, 2017 .

The Palliative Prognostic (PaP) Score without Clinical Evaluation Predicts Early Mortality among Advanced NSCLC Patients Treated with Immunotherapy

M. Maltoni, A. Ardizzoni, F. Sperandi, 2022, Cancers.

Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis

V. Ambrosini, C. Nanni, S. Fanti, 2018, European Journal of Nuclear Medicine and Molecular Imaging.

Chemotherapy treatment in malignant pleural mesothelioma: a difficult history.

A. Ardizzoni, F. Sperandi, B. Melotti, 2018, Journal of thoracic disease.

Position Paper of the Italian Association of Medical Oncology on Early Palliative Care in Oncology Practice (Simultaneous Care)

M. Maltoni, R. Labianca, L. Cavanna, 2017, Tumori.

The prognostic role of body-mass index (BMI) for advanced EGFR positive non-small cell lung cancer (NSCLC) patients treated with osimertinib.

A. Ardizzoni, F. Sperandi, B. Melotti, 2021 .

A New Regimen of Cisplatin, Epirubicin and Methotrexate (PEM-3) as Primary Chemothfrapy for Locally Advanced Bladder Cancer

F. Pannuti, B. Melotti, C. Zamagni, 1996, Tumori.

Chemotherapy with cisplatin, epirubicin, methotrexate in the treatment of locally advanced or metastatic transitional cell cancer of the bladder (TCC).

F. Pannuti, B. Melotti, G. Lelli, 1992, Journal of chemotherapy.

Activity of high-dose epirubicin in advanced non-small cell lung cancer.

F. Pannuti, B. Melotti, A Martoni, 1991, European journal of cancer.

BRAF‐mutated malignant melanoma with chondrosarcomatous differentiation in inguinal nodal metastasis

A. Altimari, B. Corti, F. Sperandi, 2021, Clinical case reports.

Combination Chemotherapy With Mitoxantrone, Methotrexate, and Mitomycin (MMM Regimen) in Malignant Pleural Mesothelioma: A Phase II Study

F. Pannuti, C. Pinto, B. Melotti, 2001, American journal of clinical oncology.

Folinic acid plus 5-FU based chemotherapy in squamous cell carcinoma of the head and neck: Bologna experience.

F. Pannuti, B. Melotti, A. Martoni, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

High-dose epirubicin for untreated patients with advanced tumours: a phase I study.

F. Pannuti, A. Riva, B. Melotti, 1990, European journal of cancer.

Drug‐induced photosensitivity during tebentafusp treatment for metastatic uveal melanoma: A newly described occurrence

F. Comito, B. Melotti, E. Dika, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

Frequency of somatic mutations in head and neck melanoma: A single‐institution experience

M. Fiorentino, A. Altimari, A. Patrizi, 2020, Pigment cell & melanoma research.

New disappearance of complicated atheromatous plaques on rechallenge with PD-1/PD-L1 axis blockade in non-small cell lung cancer patient: follow up of an unexpected event

M. Fiorentino, A. Ardizzoni, C. Borghi, 2020, Therapeutic advances in medical oncology.

Planned sequence of gemcitabine followed by vinorelbine in the treatment of elderly patients with advanced non-small cell lung cancer.

B. Melotti, F. Di Fabio, A. Martoni, 2006, Anticancer research.

Response to Osimertinib in Choroidal Metastases from EGFRmt T790M-Positive Non-Small Cell Lung Adenocarcinoma.

A. Ardizzoni, A. Ciardella, F. Sperandi, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Predictors of Survival to Immunotherapy and Chemoimmunotherapy in Non-Small Cell Lung Cancer: A Meta-Analysis.

A. Ardizzoni, F. Sperandi, B. Melotti, 2022, Journal of the National Cancer Institute.

Autoimmune bullous dermatoses in cancer patients treated by immunotherapy: a literature review and Italian multicentric experience

C. De Simone, P. Quaglino, M. Ardigó, 2023, Frontiers in medicine.

Pharmacokinetics of PTT-119 in man.

F. Pannuti, B. Melotti, A. Martoni, 1988, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy.

Acute kidney injury as a possible immune-related adverse event associated with sustained complete response to BRAF and MEK inhibitors in advanced, V600E-mutated melanoma.

A. Ardizzoni, F. Sperandi, B. Melotti, 2021, European journal of cancer.

Phase I study of sorafenib and cisplatin/pemetrexed regimen in untreated malignant pleural mesothelioma (MPM) patients: Italian SoMe Study.

V. Torri, F. Massari, C. Pinto, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

RASopathic alopecia: hair changes associated with vemurafenib therapy.

B. Piraccini, M. Starace, A. Patrizi, 2015, Journal of the American Academy of Dermatology.

Human papillomavirus evaluation of vemurafenib‐induced skin epithelial tumors: a case series

B. Melotti, S. Venturoli, E. Dika, 2015, The British journal of dermatology.

Listening understanding and acting (lung): focus on communicational issue in thoracic oncology

Vito Barbieri, Paola Mazzanti, Claudia Yvonne Finocchiaro, 2019, Translational Cancer Research.

Effective retreatment with osimertinib in CNS-relapsed epidermal growth factor receptor-mutant non-small cell lung cancer patient following resection and adjuvant osimertinib

A. Ardizzoni, F. Sperandi, B. Melotti, 2023, Anti-cancer drugs.

Arterial Embolization During Programmed Death-1 Inhibitor Treatment: An Unexpected Finding.

A. Ardizzoni, F. Sperandi, B. Melotti, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.